Rat bone marrow mesenchymal stem cells undergo malignant transformation via indirect co-cultured with tumour cells

Cell Biochemistry and Function

Volumn 30, Issue 8, 2012, Pages 650-656

  Liu, Jianping ^a   Zhang, Yalan ^b   Bai, Lu ^a   Cui, Xiangrong ^a   Zhu, Jing ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b Xi'an CDC   (China)

Author keywords

Malignant transformation; Mesenchymal stem cells; P53; Tumour microenvironment

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CACHEXIA; CANCER INVASION; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME ANALYSIS; COCULTURE; CONTROLLED STUDY; CYTOLOGY; FLOW CYTOMETRY; GLIOMA CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; MALE; MALIGNANT TRANSFORMATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCOLIOSIS; TUMOR CELL CULTURE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; BONE MARROW CELLS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; COCULTURE TECHNIQUES; FLOW CYTOMETRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KARYOTYPE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICROSCOPY, FLUORESCENCE; MUTATION; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS C-MDM2; RATS; RECEPTORS, TRANSFERRIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR PROTEIN P53;

MUS; RATTUS;

EID: 84870721871     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2844     Document Type: Article

References (40)

1. Aguilar S, Nye E, Chan J, Loebinger M, Spencer-Dene B, Fisk N. Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 2007; 25: 1586-1594.
2. Albrecht S, Connelly JH, Bruner JM. Distribution of p53 protein expression in gliosarcomas:an immunohistochemical study. Acta Neuropathol 1993; 85(2): 222-226.
3. Chen J, Baydoun AR, Xu R, et al. Lysophosphatidic acid protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis. Stem Cells 2008; 26: 135-145.
4. Donehower LA, Godley LA, Aldaz CM, et al. The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer model. Prog Clin Biol Res 1996; 395: 1-11.
5. Duesberg P, Li R. Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle 2003; 2: 202-210.
6. 5. Feldser DM, Hackett JA, Greider CW. Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer 2003; 3: 623-627.
7. Foudah D, Redaelli S, Donzelli E, et al. Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells. Chromosome Res 2009; 17: 1025-1039.
8. Fu XF, Li He Y, Yang F. Comparative investigation of BrdU, CFSE and GFP as markers of rat MSCs. J Fourth Mil Med Univ 2008; 29: 399-402.
9. Guilak F, Cohen DM, Estes BT, Gimble JM, Liedtke W, Chen CS. Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell 2009; 5: 17-26.
10. Hall B, Andreeff M, Marini F. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 2007; 180: 263-283.
11. Hamada H, Kobune M, Nakamura K, et al. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 2005; 96: 149-156.
12. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004; 32: 414-425.
13. Javazon EH, Colter DC, Schwarz EJ, Prockop DJ. Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells 2001; 19: 219-225.
14. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-399.
15. Kucerova L, Matuskova M, Hlubinova K, Altanerova V, Atoner C. Tumor cell behavior modulation by mesenchymal stromal cells. Mol Cancer 2010; 9: 129.
16. Kuhn NZ, Tuan RS. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol 2010; 222: 268-277.
17. Lane DP. Cancer. p53, guardian of the genome. Nature 1992; 358: 15-16.
18. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890-896.
19. Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007; 101: 805-815.
20. Li H, Fan X, Kovi RC, et al. Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res 2007; 67: 10889-10898.
21. Li R, Sonik A, Stindl R, Rasnick D, Duesberg P. Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci U S A 2000; 97(7): 3236-3241.
22. Miura M, Miura Y, Padilla-Nash HM, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells to malignant transformation. Stem Cell 2006; 24: 1095-1103.
23. Mueller MM, Fusenig NE. Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells. Differentiation 2002; 70: 486-497.
24. Nakamura K, Ito Y, Kawano Y. Anti-tumor effect of genetically engineered mesenchymal stem cells in a rat gliomas. Gene Ther 2004; 11: 1155-1159.
25. Nowell PC. Foundations in cancer research. Chromosomes and cancer: the evolution of an idea. Adv Cancer Res 1993; 62: 1-17.
26. Pasquinelli G, Tazzar PL, Vaselli C, et al. Thoracic aortas from multiorgan donors are suitable for obtaining resident angiogenic mesenchymal stromal cells. Stem Cells 2007; 25: 1627-1634.
27. Reilly GC, Engler AJ. Intrinsic extracellular matrix properties regulate stem cell differentiation. J Biomech 2010; 43: 55-62.
28. Rikawa E, Sun Y, Wang J, et al. Cross-platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study. BMC Genomics 2008; 9: 328.
29. Roorda BD, ter Elst A, Kamps WA, de Bont ES. Bone marrow-derived cells and tumor growth: contribution of bone marrow-derived cells to tumor micro-environments with special focus on mesenchymal stem cells. Crit Rev Oncol Hematol 2009; 69: 187-198.
30. Rosland GV, Svendsen A, Torsvik A, et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 2009; 69: 5331-5339.
31. Rubio D, Garcia-Castro J, Martin MC. Spontaneous human adult stem cell transformation. Cancer Res 2005; 65: 3035-3039.
32. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 2001; 61: 818-822.
33. Slack A, Shohet JM. MDM2 as a critical effector of the MYCN oncogene in tumorigenesis. Cell Cycle 2005; 4: 857-860.
34. Stagg J. Mesenchymal stem cells in cancer. Stem Cell Rev 2008; 4: 119-124.
35. Tarapore P, Fukasawa K. p53 mutation and mitotic infidelity. Cancer Invest 2000; 18: 148-155.
36. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007; 25: 371-379.
37. Wu YY, Huang Q, Dong J. Correlation of stem cell niche to genesis and development of Tumor Stem Cells. Cancer Res 2008; 27: 109-112.
38. Yen HC, Xu Q, Chou DM, Zhao Z, Elledge SJ. Global protein stability profiling in mammalian cells. Science 2008; 322(5903): 918-923.
39. Zhang S, Han Z, Kong Q, et al. Malignant transformation of rat bone marrow-derived mesenchymal stem cells treated with 4-nitroquinoline 1-oxide. Chem Biol Interact 2010; 188: 119-126.
40. Zhou YF, Bosch-Marce M, Okuyama H, et al. Spontaneous Transformation of Cultured Mouse Bone Marrow-Derived Stromal Cells. Cancer Res 2009; 66: 10849-10854.